Related references
Note: Only part of the references are listed.Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease
John E. Casida et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Complexity of dopamine metabolism
Johannes Meiser et al.
CELL COMMUNICATION AND SIGNALING (2013)
Astrocytes Protect Neurons against Methylmercury via ATP/P2Y1 Receptor-Mediated Pathways in Astrocytes
Yusuke Noguchi et al.
PLOS ONE (2013)
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
Arthur G. Fitzmaurice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Role of De Novo Catecholamine Synthesis in Mediating Methylmercury-Induced Vesicular Dopamine Release From Rat Pheochromocytoma (PC12) Cells
Chelsea T. Tiernan et al.
TOXICOLOGICAL SCIENCES (2013)
Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system
David W. Anderson et al.
BRAIN RESEARCH (2011)
Methylmercury inhibits electron transport chain activity and induces cytochrome c release in cerebellum mitochondria
Nobuko Mori et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2011)
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Methylmercury inhibits dopaminergic function in rat pup synaptosomes in an age-dependent manner
Anne Dreiem et al.
NEUROTOXICOLOGY AND TERATOLOGY (2009)
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: The role of aldehyde dehydrogenase
Satori A. Marchitti et al.
PHARMACOLOGICAL REVIEWS (2007)
Brain monoaminergic neurotransmission parameters in weanling rats after perinatal exposure to methylmercury and 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153)
Anna F. Castoldi et al.
BRAIN RESEARCH (2006)
Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour of rats
P Beyrouty et al.
NEUROTOXICOLOGY AND TERATOLOGY (2006)
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia
D Galter et al.
NEUROBIOLOGY OF DISEASE (2003)
3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis
WJ Burke et al.
BRAIN RESEARCH (2003)
Structural comparison of human monoamine oxidases A and B -: Mass spectrometry monitoring of cysteine reactivities
F Hubálek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mechanism of action of methylmercury on in vivo striatal dopamine release -: Possible involvement of dopamine transporter
LRF Faro et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
I Lamensdorf et al.
BRAIN RESEARCH (2000)
Share Paper
